Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2018
The 8th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland
Presentation Date(s):- Apr 11 - 14, 2018
- Total Presentations: 407
-
+
Second line in non-oncogene addiction
- Type: Educational session
- Presentations: 5
- Moderators:E. Garon
- Coordinates: 4/12/2018, 09:00 - 10:30, Room B
-
+
Chemotherapy combined with antiangiogenics: Which patients and when?
09:00 - 09:20 | Presenter: M. Garassino
- Abstract
No abstract available for this presentation
-
+
Immunotherapy: Which patients and when?
09:20 - 09:40 | Presenter: E. Garon
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Hyperprogressive disease in second-line
09:40 - 10:00 | Presenter: B. Besse
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
New promising strategies in second-line
10:00 - 10:20 | Presenter: J. Remon-Masip
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Q&A
10:20 - 10:30
- Abstract
No abstract available for this presentation
-
+
Poster Display session (Friday)
- Type: Poster Display session
- Presentations: 197
- Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
-
+
196TiP - CheckMate 384: A phase 3b/4 dose-frequency optimization trial of nivolumab in advanced or metastatic NSCLC
12:50 - 12:50 | Presenter: E. Garon
- Abstract
Loading...